NCT03290625View on ClinicalTrials.gov

Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II)

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

September 12, 2019

Study Completion Date

March 5, 2020

Conditions
Caries of InfancyDental Anxiety
Interventions
DRUG

Dexmedetomidine Hydrochloride

Dexmedetomidine hydrochloride (PrecedexTM), presented in ampoule containing 2 mL of 100 mcg / mL solution for injection

DRUG

Ketamine Hydrochloride

Dextrocetamine hydrochloride (KetaminTM), presented in a 10 mL vial containing 50 mg / mL solution for injection

Trial Locations (1)

74605220

Dental School, Goiânia

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de Goiás (FAPEG)

UNKNOWN

lead

Universidade Federal de Goias

OTHER

NCT03290625 - Intranasal Sedation With Dexmedetomidine and Ketamine in Pediatric Dentistry (NASO II) | Biotech Hunter | Biotech Hunter